$WRB

W.R. Berkley (NYSE:WRB) Misses Q3 2026 Sales Expectations, Stock Drops

W. R. Berkley (WRB) reported Q3 2026 sales of $3.74 billion, missing estimates by 2.5%. Net premiums earned were $3.21 billion, in line with expectations. The combined ratio beat estimates by 77.1 basis points, while adjusted EPS met expectations. Book value per share grew 5% year-on-year but missed estimates by 11.8%.

Original reporting
Published Oct 19, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
W.R. Berkley (NYSE:WRB) Misses Q3 2026 Sales Expectations, Stock Drops — source image
Decision brief

The 30-second read

$WRBBearishMed
01

Why it matters

The earnings miss is likely to trigger a short-term decline in WRB shares, though the combined ratio beat suggests operational efficiency.

02

Market read

Earnings miss for a mid-cap insurer; traders may adjust positions based on downside risk.

03

What to watch

Potential cost control improvements and combined ratio beat may offset revenue shortfall in the longer term.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

W.R. Berkley reported Q3 2026 results with slight revenue miss and a notable book value per share shortfall.

Company-level read

Ticker impact

$WRBBearishHigh confidence
Context

Q3 2026 earnings miss on revenue and book value per share, causing the stock to drop.

Expected impact

downward pressure as investors price in the revenue and book value miss

Evidence & confidence

The company reported revenue $3.74B vs $3.83B estimate and book value $25.87 vs $29.32 estimate, prompting a sell-off.

Market effects

Insurance sector may see broader scrutiny as earnings miss highlights pricing pressure.

U.S. insurers could face heightened volatility in the near term.

Limited to U.S. market; minimal global spillover.

Counterpoint

If the miss is viewed as a temporary setback, the stock could be a buying opportunity at lower levels.

Key entities

  • W.R. Berkley

    U.S.-listed insurance holding company (NYSE:WRB).

Related articles

$WRBMedAI 8/10

W.R. Berkley stock dips as Q3 net premiums written, ROE miss estimates

W. R. Berkley's Q3 net premiums written and ROE missed estimates, despite operating income per share beating expectations. Shares fell 4.28% to $70.94 in post-market trading. Total revenue decreased to $3.74B from $3.77B a year ago, below the $3.83B consensus. Net investment income grew to $383.54M from $351.24M, but fell short of the $413.85M estimate.

$WRBHighAI 8/10

W.R. Berkley stock slips over 3% on Q3 top-line miss

W.R. Berkley Corp (WRB) reported Q3 adjusted EPS of $1.17, beating estimates, but revenue of $3.74B missed expectations. Shares fell 3.4% in after-hours trading. Revenue grew 1.8% YoY, while net income declined. The company reported strong returns on equity and improved underwriting income.

$WRBHigh

W.R. Berkley: Q3 Earnings Snapshot

W.R. Berkley (WRB) reported Q3 net income of $446M, or $1.14 per share, beating analyst estimates. Adjusted EPS was $1.17. Revenue was $3.74B, missing expectations of $3.8B. The company's results were compared to Zacks Investment Research's analyst forecasts.